NuVision Competitors and Similar CompaniesClear all

NuVision's competitors and similar companies include Dermavant Sciences, Aerie Pharmaceuticals, Alnylam Pharmaceuticals and Sorrento Therapeutics.
NuVision
NuVision
NuVision is a biotechnology research and development spin-out company.
Dermavant Sciences
Dermavant Sciences
Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.
Aerie Pharmaceuticals
Aerie Pharmaceuticals
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Founding Date
Founding Date
2015
Founding Date
2016
Founding Date
2005
Founding Date
2002
Founding Date
2006
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Nottingham, GB HQ
Locations
Long Beach, US HQ
Basel, CH
Durham, US
Morrisville, US
New York, US
Phoenix, US
Locations
Irvine, US HQ
Dublin, IE
千代田区, JP
Henley On Thames, GB
Bedminster, US
Durham, US
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
San Diego, US HQ
San Diego, US
Employees
Employees
18
Employees
3101% decrease
Employees
3808% increase
Employees
1,32324% increase
Employees
31019% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
722.2 m
Valuation ($)
20 b
Valuation ($)
168.4 m
Twitter followers
Twitter followers
355
Twitter followers
1 k
Twitter followers
N/A
Twitter followers
16.3 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
83.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
86.96%
Percentage of tweets with engagement (last 30 days)
N/A
Employee Rating
Employee Rating
4
Employee Rating
4.9
Employee Rating
3.1
Employee Rating
4.2
Employee Rating
3.4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$194.1m (FY, 2021)
Revenue (est.)
$1.8b (FY, 2023)
Revenue (est.)
$62.8m (FY, 2022)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$26.8m (FY, 2021)
Cost of goods
$268.2m (FY, 2023)
Cost of goods
N/A
Net income
Net income
N/A
Net income
($255.3m) (FY, 2019)
Net income
($74.8m) (FY, 2021)
Net income
($440.2m) (FY, 2023)
Net income
($577.8m) (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 3m
Total funding raised
$ 200m
Total funding raised
$ 388.6m
Total funding raised
$ 1.5b
Total funding raised
$ 42.6m
For sources of this data, please see the company profile

View Company Profiles

Dermavant Sciences
HQ
Long Beach, US

Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.

View company
Aerie Pharmaceuticals
HQ
Irvine, US
Employees
380↑ 8% increase

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company